Johnson & Johnson Raises Full-Year Profit Forecast as Drug Demand Tops Expectations in Third Quarter
American company Johnson & Johnson (J&J) is raising its full-year profit forecast after demand for new cancer and autoimmune disease drugs grew more than expected in the third quarter.
Business